Chronic Rhinitis

0
Pipeline Programs
2
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Aerin Medical
Aerin MedicalCA - Mountain View
5 programs
InSeca StylusN/A1 trial
Radiofrequency StylusN/A1 trial
RhinAer ARC StylusN/A1 trial
RhinAer StylusN/A1 trial
RhinAer StylusN/A1 trial
Active Trials
NCT03727347CompletedEst. Sep 2020
NCT04684875CompletedEst. Jan 2022
NCT04614324CompletedEst. Dec 2024
+2 more trials
Neurent Medical
Neurent MedicalIreland - Galway
5 programs
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK SystemN/A1 trial
NEUROMARK™ SystemN/A1 trial
Active Trials
NCT05324397CompletedEst. Oct 2023
NCT05591989Active Not RecruitingEst. Jun 2025
NCT05937308Active Not RecruitingEst. Sep 2027
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Aerin MedicalRhinAer Stylus
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK System
Neurent MedicalNEUROMARK™ System
Aerin MedicalRadiofrequency Stylus
Aerin MedicalRhinAer ARC Stylus
Aerin MedicalRhinAer Stylus
Aerin MedicalInSeca Stylus

Clinical Trials (10)

NCT06599736Aerin MedicalRhinAer Stylus

A Study of RhinAer Stylus for Treating Chronic Rhinitis

Start: Oct 2024Est. completion: Mar 2026
N/AActive Not Recruiting
NCT06128200Neurent MedicalNEUROMARK System

NEUROMARK Randomized Controlled Trial

Start: Oct 2023Est. completion: Mar 2025
N/AActive Not Recruiting
NCT05937308Neurent MedicalNEUROMARK System

NEUROMARK Registry Study

Start: Jun 2023Est. completion: Sep 2027
N/AActive Not Recruiting
NCT05591989Neurent MedicalNEUROMARK System

Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)

Start: Sep 2022Est. completion: Jun 2025
N/AActive Not Recruiting
NCT05324397Neurent MedicalNEUROMARK System

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Start: Mar 2022Est. completion: Oct 2023
N/ACompleted
NCT04769596Neurent MedicalNEUROMARK™ System

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

Start: Feb 2021Est. completion: May 2023
N/ACompleted
NCT04684875Aerin MedicalRadiofrequency Stylus

Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device

Start: Nov 2020Est. completion: Jan 2022
N/ACompleted
NCT04614324Aerin MedicalRhinAer ARC Stylus

A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)

Start: Oct 2020Est. completion: Dec 2024
N/ACompleted
NCT04533438Aerin MedicalRhinAer Stylus

RhinAer Procedure for Treatment of Chronic Rhinitis Study

Start: Jul 2020Est. completion: Dec 2024
N/ACompleted
NCT03727347Aerin MedicalInSeca Stylus

Posterior Nasal Nerve (PNN) Rhinitis Study

Start: Oct 2018Est. completion: Sep 2020
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space